Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice

Experimental Neurology

Volumn 165, Issue 2, 2000, Pages 207-220

  Morrison, Brett M ^a   Shu, I Wei ^a   Wilcox, Amy L ^a   Gordon, Jon W ^a   Morrison, John H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cytoskeleton; Electron microscopy; Motor neurons; Neurodegeneration; Neurofilament; Sciatic nerve

Indexed keywords

NEUROFILAMENT PROTEIN; PROTEIN SUBUNIT; SUPEROXIDE DISMUTASE; TUBULIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; MOTONEURON; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCIATIC NERVE; SPINAL CORD; TRANSGENIC MOUSE;

EID: 0033802366     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7457     Document Type: Article

References (64)

1. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
2. ALS, SOD and peroxynitrite
3. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite
4. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity
5. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
6. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
7. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
8. 2+ concentration in transfected neuroblastoma SH-SY5Y cells
9. Aggregation of neurofilaments in NF-L transfected neuronal cells: Regulation of the filamentous network by a protein kinase C inhibitor
10. Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry
11. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis
12. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
13. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
14. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite
15. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L
16. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
17. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
18. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis
19. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation
20. Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells
21. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit
22. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
23. The cellular basis of cortical disconnection in Alzheimer's disease and related dementing conditions
24. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis
25. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
26. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD-1
27. Neuronal intermediate filaments
28. A mutant neurofilament subunit causes massive, selective motor neuron death: Implication for the pathogenesis of human motor neuron disease
29. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats
30. Identification of the major multiphosphorylation site in mammalian neurofilaments
31. Cytoskeletal abnormalities in motor neuron disease
32. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis
33. Neurofilament protein phosphorylation - Where, when and why
34. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II
35. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis
36. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: Neurochemical correlates of selective vulnerability
37. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice
38. Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: A putative mechanism of degeneration
39. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients
40. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis
41. Neurofilament phosphorylation: A new look at regulation and function
42. 200 Kd neurofilament protein binds Al, Cu, and Zn
43. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death aider axonal injury
44. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
45. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis
46. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms
47. Neurofilament proteins
48. cdc2-Like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization
49. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ
50. Phosphorylation of neurofilament proteins and localization of axonal swellings in motor neuron disease
51. Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias
52. Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis
53. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis
54. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
55. The topography of root fibres within the sciatic nerve trunk of the dog
56. Tyrosine modification by reactive nitrogen species: A closer look
57. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease
58. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
59. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
60. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
61. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
62. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
63. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide
64. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation